Annovis Bio, Inc. (ANVS)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 30, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Annovis Bio, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. The correspondence emphasizes that the responsibility for the accura… | Read Filing EDGAR |
| Sep. 29, 2025 | CORRESP | Neutral/Informational | Moderate | Annovis Bio, Inc. has responded to a letter from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC requested a breakdown of expenses related t… | Read Filing EDGAR |
| Sep. 19, 2025 | CORRESP | Neutral/Informational | Low | Annovis Bio, Inc. has responded to the SEC's request for additional disclosure regarding its research and development expenses in its Form 10-K for the fiscal year ended December … | Read Filing EDGAR |
| Sep. 4, 2025 | UPLOAD | Concern from SEC | High | The SEC has issued a comment letter to Annovis Bio, Inc. regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC is requesting additional information about … | Read Filing EDGAR |